Merck Plots 950-Job R&D Hub in London Post author:Sam Post published:November 26, 2017 Post category:BioPharma The move is in part related to Brexit, the UK’s exit from the European Union. Source: BioSpace You Might Also Like Biosimilars Giant Takes the Plunge Into Original Biotech Drugs Via Takeda Deal August 20, 2017 Ignyta Reports Granting Of Inducement Awards September 17, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
